InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Goodman Daniel Wintner, Director. Director active across 1 companies, notably Tonix Pharmaceuticals Holding Corp.. Aggregated, 2 disclosures have been logged. Total volume traded: €9k. The latest transaction was disclosed on 25 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€4,5725,000 shares@ €0.9144100.0% of flow
Common Stock
SEC:0001387131-21-006089·
Ideal exit: 19 Feb 2022 (T+270)
€4,5725,000 shares@ €0.91440.0018% mcap50.0% of flow
Common Stock
SEC:0001387131-21-006089:0·
Ideal exit: 19 Feb 2022 (T+270)
2 of 2 declarations
About Goodman Daniel Wintner
Daniel Wintner Goodman is a Director at Tonix Pharmaceuticals Holding Corp. As a board member, he contributes to the strategy and governance of the company. His experience is valuable in guiding Tonix towards its objectives.
